期刊文献+

脉管浸润在胃癌患者预后预测中的作用 被引量:1

Role of lymphovascular invasion in predicting the prognosis of patients with gastric cancer
下载PDF
导出
摘要 目的探讨脉管浸润在胃癌患者预后预测中的作用。方法回顾性分析2012年1月至2017年1月在陕西省人民医院普外科接受根治性胃癌手术患者的临床资料,采用HE染色和免疫组化两种方法对患者进行脉管浸润的评估。采用χ2检验分析脉管浸润与患者临床病理特征之间的关系,采用单因素和多因素分析法来确定影响患者无病生存期和总生存期的预后因素。结果在273例胃癌手术患者中,26.0%(71/273)被诊断为脉管浸润,22例为单纯的血管浸润,25例为单纯的淋巴管浸润,剩余24例患者同时存在淋巴管与血管浸润。进一步分析发现,随着肿瘤TNM分期的升高,脉管浸润的发生率呈递增趋势,从Ⅰ期胃癌的7.7%上升到Ⅲ期胃癌的36.8%(P<0.05);脉管浸润还与胃癌的肿瘤部位、病理T分期和病理N分期有关(P<0.05)。脉管浸润是胃癌患者无病生存期(相对风险比为1.5,95%置信区间为1.1~2.2,P=0.018)和总生存期(相对风险比为1.8,95%置信区间为1.3~2.6,P=0.001)的独立预测因子。结论脉管浸润是可手术胃癌患者复发和转移的高危因素,同时也是胃癌预后不佳的独立预测因子,在完善胃癌的TNM分期和监测术后复发转移中发挥重要作用。 Objective To explore the role of lymphovascular invasion in predicting the prognosis of patients with gastric cancer.Methods The clinical data of patients who underwent radical gastric cancer surgery in the general surgery department of Shaanxi provincial people's hospital from January 2012 to January 2017 were retrospectively analyzed.The lymphovascular invasion was evaluated by two methods of HE staining and immunohistochemistry.Theχ2 test was used to analyze the relationship between lymphovascular invasion and clinicopathological features of the patients,and univariate and multivariate analyses were used to determine the prognostic factors affecting disease-free survival and overall survival of the patients.Results Among the 273 patients undergoing surgery for gastric cancer,26.0%(71/273)were diagnosed as lymphovascular invasion,including 22 cases of simple vascular invasion,25 cases of simple lymphatic invasion,and 24 cases of both lymphatic and vascular invasion.Further analysis showed that,with the increase of TNM stage,the incidence of lymphovascular invasion increased from 7.7%of stageⅠgastric cancer to 36.8%of stageⅢgastric cancer(P<0.05);lymphovascular invasion were also related to tumor location,pathological T stage and pathological N stage of gastric cancer(P<0.05).Lymphovascular invasion was an independent predictor of disease-free survival(relative risk ratio:1.5,95%confidence interval:1.1-2.2,P=0.018)and overall survival(relative risk ratio:1.8,95%confidence interval:1.3-2.6,P=0.001).Conclusion Lymphovascular invasion is a high-risk factor for recurrence and metastasis of operable gastric cancer,and is also an independent predictor of poor prognosis of gastric cancer.It plays an important role in improving TNM staging of gastric cancer and monitoring postoperative recurrence and metastasis.
作者 张鸿 李伟 毛智军 王辉 侯峰 刘斐 史孟杰 ZHANG Hong;LI Wei;MAO Zhijun;WANG Hui;HOU Feng;LIU Fei;SHI Mengjie(Vascular Surgery Department,Shaanxi Provincial People's Hospital,Xi'an 710068,China;No.2 General Surgery Department,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
出处 《临床医学研究与实践》 2021年第28期43-46,共4页 Clinical Research and Practice
基金 西安市科技计划项目[No.20YXYJ0002(9)]。
关键词 胃癌 脉管浸润 预后 复发转移 gastric cancer lymphovascular invasion prognosis recurrence and metastasis
  • 相关文献

参考文献2

二级参考文献14

  • 1Nawfal R Hussein.Helicobacter pylori and gastric cancer in the Middle East: A new enigma?[J].World Journal of Gastroenterology,2010,16(26):3226-3234. 被引量:3
  • 2Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)
  • 3Masahiro Asaka.A new approach for elimination of gastric cancer deaths in Japan[J].Int J Cancer.2012(6)
  • 4Xavier Calvet,María‐José Ramírez Lázaro,Philippe Lehours,Francis Mégraud.Diagnosis and Epidemiology of H elicobacter pylori Infection[J].Helicobacter.2013
  • 5Kamran Aryana,Mohammad Keramati,Seyed Zakavi,Mohammad Sadeghian,Hedieh Akbari.Association of Helicobacter pylori infection with the Lewis and ABO blood groups in dyspeptic patients[J].Nigerian Medical Journal.2013(3)
  • 6Richard Kim,Ann Tan,Minsig Choi,Bassel F. El-Rayes.Geographic differences in approach to advanced gastric cancer: Is there a standard approach?[J].Critical Reviews in Oncology / Hematology.2013
  • 7Ye Hu,Jing Yuan Fang,Shu Dong Xiao.Can the incidence of gastric cancer be reduced in the new century?[J].Journal of Digestive Diseases.2012(1)
  • 8Takeshi Matsuhisa,Hafeza Aftab.Observation of Gastric Mucosa in B angladesh, the Country with the Lowest Incidence of Gastric Cancer, and J apan, the Country with the Highest Incidence[J].Helicobacter.2012(5)
  • 9Ji Yeon Kim,Hye Seung Lee,Nayoung Kim,Cheol Min Shin,Sang Hyub Lee,Young Soo Park,Jin‐Hyeok Hwang,Jin‐Wook Kim,Sook‐Hyang Jeong,Dong Ho Lee,Do Joong Park,Hyung Ho Kim,Hyun Chae Jung.Prevalence and Clinicopathologic Characteristics of Gastric Cardia Cancer in South Korea[J].Helicobacter.2012(5)
  • 10Brigette BY Ma,Edwin P Hui,Tony SK Mok.Population-based differences in treatment outcome following anticancer drug therapies[J].Lancet Oncology.2010(1)

共引文献177

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部